EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A review of the safety, efficacy, and administration of hedgehog inhibitors for the treatment of advanced basal cell carcinoma: an expert consensus panel

Milaan Shah, Lauren Debusk, Angela Rosenberg, Joshua Burshtein, Danny Zakria, Mohammed Dany, Scott Dinehart, Mark Lebwohl, Jesse Lewin, George Monks, Michael Mortazie, Todd Schlesinger und 2 weitere

Dermatology Online Journal · 2025

DOI: 10.25251/s3cn8t86 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Dermatology Online Journal, 2025. Verfasst von Milaan Shah und 13 weiteren Autor:innen. Beteiligte Einrichtung: MUSC. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Skin Neoplasms, Pyridines, Hedgehog Proteins. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hedgehog inhibitors (HHIs) are approved for the treatment of locally advanced BCCs in patients who are not surgical candidates or have had recurrence following surgical treatment. This expert consensus panel further characterizes the efficacy and safety of HHIs while also providing clinical guidance on their appropriate dosing, laboratory monitoring, and supplementation.

Methods

A comprehensive literature review was completed on November 1, 2024 using the keywords “basal cell carcinoma,” “hedgehog inhibitor,” “sonidegib,” and “vismodegib”. An expert panel of nine dermatologists reviewed and assigned levels of evidence to the relevant articles and created consensus statements regarding HHIs, with correlating strength of recommendations, using the modified Delphi process.

Results

Of the 304 articles identified, 23 articles met the selection criteria and were included for review. The panel unanimously adopted nine consensus statements and recommendations, of which three were given a strength of recommendation of “A”, two were given a “B”, and four were given a “C”.

Conclusion

Sonidegib and vismodegib have similar efficacy in treating advanced BCC, but sonidegib has lower rates and a greater delay in onset of AEs. Sonidegib has a significantly greater volume of distribution and half-life than those of vismodegib. Dosing interruptions have not been shown to reduce the efficacy of HHIs, and L-carnitine supplementation can help reduce the incidence of muscle spasms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basal Cell CarcinomaSkin NeoplasmsPyridinesHedgehog ProteinsAnilidesBiphenyl CompoundsAntineoplastic AgentsHumansConsensus

Stichwörter der Autor:innen

treatmentSkin cancerbasal cell carcinomaexpert consensushedgehog inhibitorssonidegib

Substanzen

HhAntag691PyridinessonidegibHedgehog ProteinsAnilidesBiphenyl CompoundsAntineoplastic Agents

Autor:innen und Institutionen

  • MUSC.

Zitieren

APA

Shah, M., Debusk, L., Rosenberg, A., Burshtein, J., Zakria, D., Dany, M., Dinehart, S., Lebwohl, M., Lewin, J., Monks, G., Mortazie, M., Schlesinger, T., Trotter, S., & Rigel, D. (2025). A review of the safety, efficacy, and administration of hedgehog inhibitors for the treatment of advanced basal cell carcinoma: an expert consensus panel. Dermatology Online Journal. https://doi.org/10.25251/s3cn8t86

Vancouver

Shah M, Debusk L, Rosenberg A, Burshtein J, Zakria D, Dany M, et al. A review of the safety, efficacy, and administration of hedgehog inhibitors for the treatment of advanced basal cell carcinoma: an expert consensus panel. Dermatology Online Journal. 2025. doi:10.25251/s3cn8t86

BibTeX
@article{Shah2025,
  author = {Shah, Milaan and Debusk, Lauren and Rosenberg, Angela and Burshtein, Joshua and Zakria, Danny and Dany, Mohammed and Dinehart, Scott and Lebwohl, Mark and Lewin, Jesse and Monks, George and Mortazie, Michael and Schlesinger, Todd and Trotter, Shannon and Rigel, Darrell},
  title = {A review of the safety, efficacy, and administration of hedgehog inhibitors for the treatment of advanced basal cell carcinoma: an expert consensus panel},
  journal = {Dermatology Online Journal},
  year = {2025},
  doi = {10.25251/s3cn8t86}
}
Kostenlos starten →